Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus

B Raman, DA Bluemke, TF Lüscher… - European heart …, 2022 - academic.oup.com
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …

[HTML][HTML] Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection

JM Adrover, L Carrau, J Daßler-Plenker, Y Bram… - JCI insight, 2022 - ncbi.nlm.nih.gov
Severe acute lung injury has few treatment options and a high mortality rate. Upon injury,
neutrophils infiltrate the lungs and form neutrophil extracellular traps (NETs), damaging the …

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective

S Halawa, SS Pullamsetti, CRM Bangham… - Nature Reviews …, 2022 - nature.com
The lungs are the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, with severe hypoxia being the cause of death in the most critical cases …

Post-COVID syndrome: pulmonary complications

D Esendağli, A Yilmaz, MŞ AKÇAY… - Turkish journal of …, 2021 - journals.tubitak.gov.tr
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of
people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease …

Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies

H Christou, RA Khalil - American Journal of Physiology …, 2022 - journals.physiology.org
Pulmonary hypertension (PH) is a serious disease characterized by various degrees of
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …

Molecular pathways in pulmonary arterial hypertension

AJ Shah, M Vorla, DK Kalra - International Journal of Molecular Sciences, 2022 - mdpi.com
Pulmonary arterial hypertension is a multifactorial, chronic disease process that leads to
pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in …

Cardiopulmonary exercise testing as a vital sign in patients recovering from COVID-19

R Arena, MA Faghy - Expert review of cardiovascular therapy, 2021 - Taylor & Francis
Countries around the world continue to address the largescale health and wellbeing impacts
and the broader societal burden associated with the coronavirus disease 2019 (COVID …

Severe pulmonary hypertension: an important sequel after severe post-acute COVID-19 pneumonia

G Cueto-Robledo, M Porres-Aguilar… - Current Problems in …, 2022 - Elsevier
Discussion According to data referring to previous epidemics, 70-80% of patients who
survived coronavirus infections such as SARS and MERS, presented respiratory …

[HTML][HTML] Post pandemic research priorities: a consensus statement from the HL-PIVOT

MA Faghy, R Arena, AS Babu, JW Christle… - Progress in …, 2022 - Elsevier
We have been amid unhealthy living and related chronic disease pandemics for several
decades. These longstanding crises have troublingly synergized with the coronavirus …

Recent advances and future prospects of treatment of pulmonary hypertension

A Hajra, I Safiriyu, P Balasubramanian, R Gupta… - Current Problems in …, 2023 - Elsevier
Pulmonary hypertension is one of the difficult situations to treat. Complex pathophysiology,
association of the multiple comorbidities make clinical scenario challenging. Recently it is …